Clicky

LEAP THERAPEUTICS, INC.(LPTX) News

Date Title
Aug 12 Leap Therapeutics Reports Second Quarter 2024 Financial Results
May 13 Leap Therapeutics Inc (LPTX) Q1 2024 Earnings: Financial Resilience Amidst Clinical Progress
May 13 Leap Therapeutics Reports First Quarter 2024 Financial Results
Apr 29 Pipeline Moves: Investigator-led trial of Lilly’s merestinib in solid tumours terminated
Apr 11 Leap Therapeutics Announces $40 Million Private Placement
Mar 20 Here's Why Leap Therapeutics (LPTX) is Poised for a Turnaround After Losing -28.92% in 4 Weeks
Mar 18 Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Jan 2 Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients
Apr 26 Leap Therapeutics to Present Updated Data from Part A of the DisTinGuish Study of DKN-01 Plus Tislelizumab and Chemotherapy in Gastric Cancer Patients at the 2023 ASCO Annual Meeting